Conolidine’s analgesic results stem from its conversation with non-opioid pain pathways. In contrast to opioids, which bind to µ-opioid receptors while in the central anxious system, conolidine modulates alternate molecular targets. A Science Advancements study discovered that conolidine interacts With all the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid https://terryq245alx0.wonderkingwiki.com/user